Outcome of Targeted Therapy for Obstructive Sleep Apnea in Children with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Woranart Ratanakorn · 2026
Read Outcome of Targeted Therapy for Obstructive Sleep Apnea in Children with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Woranart Ratanakorn (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605578.txt.
Description
Woranart Ratanakorn studies children who live with both blocked airways in sleep and fatty liver disease tied to obesity. The study followed 127 children aged four to eighteen, all with confirmed sleep apnea and liver fat on ultrasound, seen between 2018 and 2025. Sixty-seven received targeted treatment, either tonsil and adenoid surgery or a nightly air-pressure mask. The rest received non-targeted care. Sleep studies, liver enzymes, and liver scans were checked again after six to twelve months.
The targeted group improved in apnea severity, night oxygen levels, liver enzymes, and liver fat, while the other group trended worse. The air-pressure mask showed the strongest link to a large drop in a key liver enzyme. Weight change alone did not explain the liver gains. The author notes that only planned prospective studies can show whether the treatment itself causes the benefit.
Catalog record
| CREATOR | Woranart Ratanakorn |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |